# Atrial Fibrillation Management and Outcomes

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the management, treatment, and risk assessment of atrial fibrillation (AF). It covers topics such as anticoagulant therapy, catheter ablation, stroke prevention, risk stratification, and guidelines for managing AF. The papers also compare different medications such as warfarin, rivaroxaban, and dabigatran for the treatment of AF. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10065 |
| Works | 662 |

## Topic papers all

Showing 15 of 662.

- [Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis](https://scholariq.org/papers/aspirin-plus-clopidogrel-as-secondary-prevention-after-stroke-or-transient/)
- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/2017-esc-guidelines-for-the-management-of-acute-myocardial-infarction-in/)
- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation](https://scholariq.org/papers/2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial/)
- [Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/ticagrelor-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/esc-guidelines-for-the-management-of-acute-myocardial-infarction-in-patients/)
- [Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/prasugrel-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-5/)
- [2017 ESC/EACTS Guidelines for the management of valvular heart disease](https://scholariq.org/papers/2017-esc-eacts-guidelines-for-the-management-of-valvular-heart-disease/)
- [Prevalence of Diagnosed Atrial Fibrillation in Adults](https://scholariq.org/papers/prevalence-of-diagnosed-atrial-fibrillation-in-adults/)
- [Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)](https://scholariq.org/papers/guidelines-for-the-management-of-atrial-fibrillation-the-task-force-for-the/)

## Topic primary papers

Showing 15 of 356.

- [Dabigatran versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/dabigatran-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2020-esc-guidelines-for-the-diagnosis-and-management-of-atrial-fibrillation/)
- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation](https://scholariq.org/papers/2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS](https://scholariq.org/papers/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-5/)
- [Prevalence of Diagnosed Atrial Fibrillation in Adults](https://scholariq.org/papers/prevalence-of-diagnosed-atrial-fibrillation-in-adults/)
- [Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)](https://scholariq.org/papers/guidelines-for-the-management-of-atrial-fibrillation-the-task-force-for-the/)
- [Edoxaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/edoxaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials](https://scholariq.org/papers/comparison-of-the-efficacy-and-safety-of-new-oral-anticoagulants-with-warfarin/)
- [Validation of Clinical Classification Schemes for Predicting Stroke](https://scholariq.org/papers/validation-of-clinical-classification-schemes-for-predicting-stroke/)
- [Impact of Atrial Fibrillation on the Risk of Death](https://scholariq.org/papers/impact-of-atrial-fibrillation-on-the-risk-of-death/)
- [2012 focused update of the ESC Guidelines for the management of atrial fibrillation](https://scholariq.org/papers/2012-focused-update-of-the-esc-guidelines-for-the-management-of-atrial/)
- [2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation](https://scholariq.org/papers/2014-aha-acc-hrs-guideline-for-the-management-of-patients-with-atrial-2/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.